[Knockdown of Puma protects cord blood CD34(+) cells against γ- irradiation]

Lei Zhao1, Hong-Yan Zhang1, Ya-Kun Pang1

  • 1State Key Laboratory of Experimental Hematology, Institute of Hematology & Blood Disease Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China.

Insights

Knocking down Puma (P53 upregulated modulator of apoptosis) in human hematopoietic stem cells reduces apoptosis and maintains cell quiescence after irradiation, conferring a radioprotective effect. This targeted approach offers a valuable tool for translational studies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Hematology

Context:

  • Puma (P53 upregulated modulator of apoptosis) is a key mediator of apoptosis in hematopoietic stem cells (HSCs).
  • Radiation exposure induces apoptosis in HSCs, impacting their function.
  • Targeting Puma offers a potential strategy for radioprotection in human HSCs.

Purpose:

  • To develop an effective lentiviral vector for targeting Puma in human hematopoietic cells.
  • To investigate the effect of Puma gene knockdown on the biological function of human cord blood CD34(+) cells.
  • To assess the radioprotective potential of Puma knockdown in human HSCs.

Summary:

  • A lentiviral vector (SF-LV-shPuma-EGFP) was developed to effectively knock down Puma expression in human cord blood CD34(+) cells.
  • Puma knockdown resulted in reduced apoptosis and sustained quiescence of CD34(+) cells post-irradiation.
  • Semi-quantitative RT-PCR, Western blot, FCM, and functional assays confirmed the radio-protective effect of Puma knockdown.

Impact:

  • Puma gene knockdown confers a significant radioprotective effect on human cord blood CD34(+) hematopoietic stem cells.
  • Targeting Puma maintains HSC quiescence, suggesting potential applications in radiation therapy and stem cell transplantation.
  • The developed lentiviral system provides a valuable tool for future translational research involving human hematopoietic cells.